Lehrer-Graiwer Joshua 4
4 · Global Blood Therapeutics, Inc. · Filed Feb 20, 2020
Insider Transaction Report
Form 4
Lehrer-Graiwer Joshua
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2020-02-18$26.90/sh+1,313$35,320→ 3,908 total - Sale
Common Stock
2020-02-18$69.71/sh−1,313$91,529→ 2,595 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-02-18−1,313→ 5,250 totalExercise: $26.90Exp: 2027-02-16→ Common Stock (1,313 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- [F2]The shares of Common Stock underlying this option shall vest in 16 equal quarterly installments over 4 years from February 17, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.